Since 1988, victims of defective drugs have turned to AttorneysTrialGroup.com for help with their personal injury or wrongful death claims. We encourage you to contact our Florida prescription drug recall attorneys today to discuss your possible pharmaceutical injury claim.

Digitek – also known as “digoxin” – is used by very ill patients with congestive heart failure or abnormal heart rhythms. In April 2008, Digitek tablets were recalled by the manufacturer, Actavis Totowa.

The pills were apparently made for an unknown period of time with a potentially fatal defect. Some tablets may have been twice as thick as they were supposed to be. That meant they could contain twice the approved level of Digitalis, the active ingredient in Digitek.

Faced with this grave risk to the public’s health, Actavis launched a Class I nationwide recall. The recalled tablets were distributed by Mylan Pharmaceuticals, Inc. under the Bertek label and by UDL Laboratories, Inc. under the UDL label.

Those double-strength pills can lead to Digitalis toxicity. Digitalis toxicity can cause a heart attack, stroke, kidney failure, nausea, vomiting, dizziness, low blood pressure and an unstable or slow heart rate. Digitalis toxicity can also lead to death. Elderly patients and patients with weak kidneys face the greatest risk.

Symptoms of Digitalis toxicity include: nausea, vomiting, diarrhea, loss of appetite, confusion, heart palpitations, irregular heartbeat, halos or rings of light around objects, and blind spots or blurred vision. Other symptoms include: decreased urine output, excessive nighttime urination, fainting, swelling and difficulty breathing when lying down.